Bolo, Reymart S.
HRN: 24-07-78 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/11/2023
CEFUROXIME 750MG (VIAL)
11/11/2023
11/18/2023
IV
240 Mg
Q8 Hrs
PCAP C
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes